Cibc Asset Management Inc Beam Therapeutics Inc. Transaction History

Cibc Asset Management Inc

  • $28.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022
SELL
$53.73 - $82.16 $147,273 - $225,200
-2,741 Closed
0 $0
Q4 2021

Feb 08, 2022
BUY
$68.02 - $99.06 $15,168 - $22,090
223 Added 8.86%
2,741 $218,000
Q3 2021

Nov 09, 2021
BUY
$84.37 - $133.6 $30,963 - $49,031
367 Added 17.06%
2,518 $219,000
Q2 2021

Aug 16, 2021
BUY
$64.12 - $128.71 $137,922 - $276,855
2,151 New
2,151 $277,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.69B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email